To Pee or Not to Pee: Prine Testing in Myeloma Response Evaluations – Monday, May 5, 2025 – The webinar will be available soon – stay tuned! CME credits / Sharon Rawet Lederer Open to access this content To Pee or Not to Pee: Prine Testing in Myeloma Response Evaluations – Monday, May 5, 2025 – The webinar will be available soon – stay tuned! Read More »
IACH Roundtable Debate – Transplant at 65+: A Still Valid Strategy or a Risk We Should Retire? – Monday, April 7, 2025 Uncategorized / Yaniv Kalif Open to access this content IACH Roundtable Debate – Transplant at 65+: A Still Valid Strategy or a Risk We Should Retire? – Monday, April 7, 2025 Read More »
IACH Journal Club-Isatuximab, bortezomib, lenalidomide, and limited dexamethasone in patients with transplant-ineligible multiple myeloma (REST): a multicentre, single-arm, phase 2 trial – Monday, March 24, 2025 CME credits / Adam Barkay Open to access this content IACH Journal Club-Isatuximab, bortezomib, lenalidomide, and limited dexamethasone in patients with transplant-ineligible multiple myeloma (REST): a multicentre, single-arm, phase 2 trial – Monday, March 24, 2025 Read More »
Hottest Myeloma Topics: Disease Outcome, MRD, Mass Spectrometry and Beyond – An IACH Round Table Discussion CME credits, Free / Adam Barkay Open to access this content Hottest Myeloma Topics: Disease Outcome, MRD, Mass Spectrometry and Beyond – An IACH Round Table Discussion Read More »
